| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | D F Mureșanu | |
| D M Stanca | |||
| I C Mărginean | |||
| O Sorițău | |||
| P2860 | cites work | Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. | Q51743594 |
| Comparison of serum S-100 protein levels following stroke and traumatic brain injury | Q62053785 | ||
| Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction | Q67782008 | ||
| Serum neurone-specific enolase as an indicator of stroke volume | Q71328350 | ||
| Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke | Q81013808 | ||
| Panel of biomarkers predicts stroke | Q81250605 | ||
| Biomarkers for stroke: in search of fingerprints | Q83630746 | ||
| Protein S-100B as biochemical marker of brain ischemic damage after treatment of carotid stenosis | Q84212753 | ||
| Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison | Q24676950 | ||
| Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia | Q28261750 | ||
| Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review | Q34088810 | ||
| Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling | Q34140261 | ||
| Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. | Q34263891 | ||
| Blood biomarkers of ischemic stroke | Q35648087 | ||
| Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review | Q36241156 | ||
| Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
| S100 as a marker of acute brain ischemia: a systematic review. | Q36984953 | ||
| Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 | ||
| Acute hemorrhagic stroke pathophysiology and medical interventions: blood pressure control, management of anticoagulant-associated brain hemorrhage and general management principles | Q37332354 | ||
| Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele | Q37457665 | ||
| The complexity of neurobiological processes in acute ischemic stroke | Q37484618 | ||
| Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment | Q37635613 | ||
| Genetics and genomics of stroke: novel approaches | Q37773049 | ||
| Plasmatic markers in hemorrhagic stroke | Q37903248 | ||
| Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study | Q37903591 | ||
| Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells | Q40319936 | ||
| Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. | Q40607050 | ||
| Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study | Q45159143 | ||
| Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers | Q46688898 | ||
| Novel diagnostic test for acute stroke | Q48118544 | ||
| Early Biomarkers of Stroke | Q48193653 | ||
| S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system | Q48211966 | ||
| Identification of novel brain biomarkers. | Q48466456 | ||
| Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. | Q48527561 | ||
| The forgotten lymphocyte: immunity and stroke | Q48559030 | ||
| Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke | Q48597436 | ||
| S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction | Q48613055 | ||
| Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. | Q48741097 | ||
| PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke | Q48788452 | ||
| A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke | Q48860420 | ||
| Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke | Q48952204 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stroke | Q12202 |
| brain ischemia | Q4862390 | ||
| biomarker | Q864574 | ||
| clinical decision-making | Q96976236 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 21-5 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of medicine and life | Q26854007 |
| P1476 | title | Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke | |
| P478 | volume | 8 Spec Issue |
Search more.